Tag: Recipharm

April 11, 2022 Off

Recipharm completes US biologics acquisitions

By Author

Recipharm, a global contract development and manufacturing organisation (CDMO), has announces the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.

February 11, 2021 Off

Recipharm bolsters biologics offering

By Dino Mustafić

Global contract development and manufacturing organisation (CDMO), Recipharm, has successfully extended its manufacturing license to include immunology products, allowing them to cater for customers’ vaccine products at clinical and commercial scales, in both freeze-dried and liquid forms.